Vous êtes ici : Accueil > Laboratoire BCI > Publications du laboratoire en 2013

Publications du laboratoire en 2013

Publié le 30 janvier 2019

Alfaidy N, Chauvet S, Andrei S, Salomon A, Saoudi Y, Richaud PR, Aude-Garcia C, Hoffmann P, Andrieux A, Moulis JM, Feige JJ and Benharouga M
Prion protein expression and functional importance in developmental angiogenesis: Role in oxidative stress and copper homeostasis.
Antioxidants and Redox Signaling, 2013, 18(4): 400-411

Bezuidt OK, Klockgether J, Elsen S, Attree I, Davenport CF and Tümmler B
Intraclonal genome diversity of Pseudomonas aeruginosa clones CHA and TB.
BMC Genomics, 2013, 14: 416-431

Boufettal H, Feige JJ, Benharouga M, Aboussaouira T, Nadifi S, Mahdaoui S, Samouh N and Alfaidy N
Rôle potentiel du facteur angiogénique « EG-VEGF » dans les maladies gestationnelles trophoblastiques.
Pathologie Biologie, 2013, 61(5): 178-183

Bouillet L, Baudet AE, Deroux A, Sidibe A, Dumestre-Perard C, Mannic T, Treillard B, Arboleas MA, Chiquet CA, Gulino-Debrac DG and Vilgrain IY
Auto-antibodies to vascular endothelial cadherin in humans: Association with autoimmune diseases.
Laboratory Investigation, 2013, 93(11): 1194-1202

Brouillet S, Hoffmann P, Thomas-Cadi C, Bergues U, Feige JJ, Alfaidy N and Hennebicq S
PROK1, biomarqueur de l’implantation embryonnaire ?
[PROK1, prognostic marker of embryo implantation?].
Gynécologie, Obstétrique & Fertilité, 2013, 41(9): 562-565

Brouillet S, Murthi P, Hoffmann P, Salomon A, Sergent F, De Mazancourt P, Dakouane-Giudicelli M, Dieudonné MN, Rozenberg P, Vaiman D, Barbaux S, Benharouga M, Feige JJ and Alfaidy N
EG-VEGF controls placental growth and survival in normal and pathological pregnancies: Case of fetal growth restriction (FGR).
Cellular and Molecular Life Sciences, 2013, 70(3): 511-525

Casabona MG, Silverman JM, Sall KM, Boyer F, Coute Y, Poirel J, Grunwald D, Mougous JD, Elsen S and Attree I
An ABC transporter and an outer membrane lipoprotein participate in posttranslational activation of type VI secretion in Pseudomonas aeruginosa.
Environmental Microbiology, 2013, 15(2): 471-486

Casabona MG, Vandenbrouck Y, Attree I and Coute Y
Proteomic characterization of Pseudomonas aeruginosa PAO1 inner membrane.
Proteomics, 2013, 13(16): 2419-2423

Chabre O, Libe R, Assie G, Barreau O, Bertherat J, Bertagna X, Feige JJ and Cherradi N
Les microARN circulants miR-483-5p et miR-195 prédisent le risque de récidive et de décès des cancers cortico-surrénaliens.
Annales d'Endocrinologie, 2013, 74(4): 269

Chabre O, Libé R, Assie G, Barreau O, Bertherat J, Bertagna X, Feige JJ and Cherradi N
Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients.
Endocrine-Related Cancer, 2013, 20(4): 579-594

Ciais D, Cherradi N and Feige JJ
Multiple functions of tristetraprolin/TIS11 RNA-binding proteins in the regulation of mRNA biogenesis and degradation.
Cellular and Molecular Life Sciences, 2013, 70(12): 2031-2044

Deshiere A, Duchemin-Pelletier E, Spreux E, Ciais D, Combes F, Vandenbrouck Y, Couté Y, Mikaelian I, Giusiano S, Charpin C, Cochet C and Filhol O
Unbalanced expression of CK2 kinase subunits is sufficient to drive epithelial-to-mesenchymal transition by Snail1 induction.
Oncogene, 2013, 32: 1373-1383

Elsen S, Collin-Faure V, Gidrol X and Lemercier C
The opportunistic pathogen Pseudomonas aeruginosa activates the DNA double-strand break signaling and repair pathway in infected cells.
Cellular and Molecular Life Sciences, 2013, 70: 4385-4397

Faudry E, Perdu C and Attree I
Pore formation by T3SS translocators: Liposome leakage assay.
Methods in Molecular Biology, 2013, 966: 173-185

Faure C, Hoffmann P, Salomon A, Garnier V, Sapin V, Blanchon L, Guibourdenche J, Benharouga M, Feige JJ and Alfaidy N
Membranes fœtales humaines, nouvelles sources et cibles du facteur endocrine EG-VEGF : implications physiologiques et physiopathologiques.
Annales d'Endocrinologie, 2013, 74(4): 312

Filhol O, Deshiere A and Cochet C
Role of CK2 in the control of cell plasticity in breast carcinoma progression In Protein kinase CK2 Edited by Pinna LA, Willey. Wiley-IUBMB Series on Biochemistry and Molecular Biology, 2013, pp 363-382

Forsman H, Bylund J, Oprea TI, Karlsson A, Boulay F, Rabiet MJ and Dahlgren C
The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third intracellular receptor loop.
Biochimica and Biophysica Acta - Molecular Cell Research, 2013, 1833(8): 1914-1923

Garnier V, Salomon A, Fournier T, Sergent F, Hoffmann P, Feige JJ and Alfaidy N
Contribution à la compréhension du mécanisme de régulation de l’invasion trophoblastique par PPARgamma : implication de l’EG-VEGF.
Annales d'Endocrinologie, 2013, 74(4): 262

Gulino-Debrac D
Mechanotransduction at the basis of endothelial barrier function.
Tissue Barriers, 2013, 1(2): e24180

Holloway A, Salomon A, Raha S, Granier V, Sergent MF, Nicholson CJ, Feige JJ, Benharouga M and Alfaidy N
Effet de l’exposition à la nicotine sur le développement placentaire : étude in vivo et in vitro.
Annales d'Endocrinologie, 2013, 74(4): 262-263

Kaspi E, Guillet B, Piercecchi-Marti MD, Alfaidy N, Bretelle F, Bertaud-Foucault A, Stalin J, Rambeloson L, Lacroix O, Blot-Chabaud M, Dignat-George F and Bardin N
Identification of soluble CD146 as a regulator of trophoblast migration: Potential role in placental vascular development.
Angiogenesis, 2013, 16(2): 329-342

Keramidas M, Josserand V, Feige JJ and Coll JL
Noninvasive and quantitative assessment of in vivo angiogenesis using RGD-based fluorescence imaging of subcutaneous sponges.
Molecular Imaging and Biology, 2013, 15(3): 239-244

Le Gouellec A, Chauchet X, Laurin D, Aspord C, Verove J, Wang Y, Genestet C, Trocme C, Ahmadi M, Martin S, Broisat A, Cretin F, Ghezzi C, Polack B, Plumas J and Toussaint B
A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy.
Molecular Therapy, 2013, 21(5): 1076-1086

Lemercier C and Elsen S
Pseudomonas aeruginosa prise en flagrant délit de casse ! .
Médecine Sciences, 2013, 11: 949-950

Levet S, Ciais D, Merdzhanova G, Mallet C, Zimmers TA, Lee SJ, Navarro FP, Texier I, Feige JJ, Bailly S and Vittet D
Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation.
Blood, 2013, 122(4): 598-607

Robert-Genthon M, Casabona MG, Neves D, Couté Y, Cicéron F, Elsen S, Dessen A and Attrée I
Unique features of a Pseudomonas aeruginosa α2-macroglobulin homolog.
MBio, 2013, 4(4): e00309-13

Saraiva RM, Waghabi MC, Vilela MF, Madeira FS, Sperandio da Silva GM, Xavier SS, Feige JJ, Hasslocher-Moreno AM and Araujo-Jorge TC
Predictive value of transforming growth factor-ß1 in Chagas disease: Towards a biomarker surrogate of clinical outcome.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 2013, 107(8): 518-525

Vilgrain I, Sidibé A, Polena H, Cand F, Mannic T, Arboleas M, Boccard S, Baudet A, Gulino-Debrac D, Bouillet L, Quesada JL, Mendoza C, Lebas JF, Pelletier L and Berger F
Evidence for post-translational processing of Vascular Endothelial (VE)-Cadherin in brain tumors: Towards a candidate biomarker.
PLoS One, 2013, 8(12): e80056

Wager B, Faudry E, Wills T, Attree I and Delcour AH
Current fluctuation analysis of the PopB and PopD translocon components of the Pseudomonas aeruginosa Type III Secretion System.
Biophysical Journal, 2013, 104 (7): 1445–1455